If a ground-glass nodule is determined to harbor an EGFR mutation, EGFR-targeted therapy may be considered for the management of the remaining lesions in patients with multiple GGNs, thus supporting the precision treatment of lung adenocarcinoma. Here, EGFR is linked to lung adenocarcinoma.